Missingness rates | Â | Treatment | Time | Treatment x Time | Coverage probability | |||||
---|---|---|---|---|---|---|---|---|---|---|
5% | Analysis | Bias | RMSE | Bias | RMSE | Bias | RMSE | Treatment | Time | Treatment x Time |
 | ML | -0.153 | 0.189 | -0.0112 | 0.018 | 0.009 | 0.022 | 87.50% | 95.30% | 95.10% |
 | MI | -0.155 | 0.191 | -0.008 | 0.017 | 0.004 | 0.022 | 86.90% | 95.50% | 94.50% |
 | LMCF | -0.155 | 0.190 | -0.033 | 0.036 | 0.011 | 0.023 | 85.90% | 95.10% | 95.30% |
 | J2R (P-) | -0.172 | 0.205 | -0.012 | 0.019 | 0.023 | 0.031 | 82.50% | 94.90% | 95.20% |
 | CDR (P-) | -0.160 | 0.195 | -0.012 | 0.019 | 0.015 | 0.025 | 87.30% | 95.10% | 94.50% |
 | CR (P-) | -0.165 | 0.199 | -0.012 | 0.018 | 0.019 | 0. 027 | 83.70% | 94.30% | 95.50% |
10% | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 | ML | 0.062 | 0.125 | 0.003 | 0.015 | 0.011 | 0.024 | 94.50% | 95.10% | 94.20% |
 | MI | 0.059 | 0.125 | -0.007 | 0.017 | 0.016 | 0.030 | 94.20% | 95.10% | 94.30% |
 | LMCF | 0.031 | 0.11 | -0.087 | 0.088 | 0.034 | 0.040 | 95.10% | 93.30% | 95.20% |
 | J2R (P-) | 0.013 | 0.110 | -0.004 | 0.016 | 0.044 | 0.050 | 94.50% | 95.20% | 96.60% |
 | CDR (P-) | 0.036 | 0.115 | -0.004 | 0.016 | 0.032 | 0.040 | 95.69% | 95.90% | 95.20% |
 | CR (P-) | 0.022 | 0.111 | -0.004 | 0.016 | 0.040 | 0. 045 | 95.30% | 95.10% | 95.60% |
20% | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
ML | -0.043 | 0.012 | -0.0061 | 0.018 | 0.009 | 0.025 | 94.10% | 94.50% | 95.30% | Â |
 | MI | -0.036 | 0.125 | -0.013 | 0.026 | 0.013 | 0.033 | 95.00% | 94.50% | 95.30% |
 | LMCF | -0.127 | 0.175 | -0.180 | 0.180 | 0.066 | 0.070 | 87.90% | 84.40% | 94.50% |
 | J2R (P-) | -0.131 | 0.177 | -0.002 | 0.017 | 0.078 | 0.083 | 86.80% | 95.30% | 95.10% |
 | CDR (P-) | -0.102 | 0.155 | -0.002 | 0.017 | 0.054 | 0.059 | 85.30% | 96.10% | 95.50% |
 | CR (P-) | -0.115 | 0.163 | -0.002 | 0.017 | 0.063 | 0. 067 | 89.60% | 95.10% | 95.40% |
30% | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 | ML | 0.062 | 0.125 | 0.003 | 0.015 | 0.011 | 0.024 | 94.50% | 95.40% | 96.30% |
 | MI | 0.059 | 0.125 | -0.007 | 0.017 | 0.016 | 0.030 | 95.10% | 94.50% | 96.20% |
 | LMCF | 0.031 | 0.11 | -0.087 | 0.088 | 0.034 | 0.040 | 94.30% | 95.50% | 94.70% |
 | J2R (P-) | 0.013 | 0.110 | -0.004 | 0.016 | 0.044 | 0.050 | 94.50% | 96.10% | 95.90% |
 | CDR (P-) | 0.036 | 0.115 | -0.004 | 0.016 | 0.032 | 0.040 | 95.10% | 94.30% | 95.50% |
 | CR (P-) | 0.022 | 0.111 | -0.004 | 0.016 | 0.040 | 0.045 | 94.50% | 95.60% | 96.20% |
50% | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 | ML | 0.153 | 0.193 | 0.055 | 0.059 | -0.071 | 0.077 | 87.80% | 94.50% | 96.10% |
 | MI | 0.144 | 0.195 | 0.050 | 0.059 | -0.063 | 0.077 | 86.30% | 95.40% | 96.10% |
 | LMCF | 0.066 | 0.143 | 0.374 | 0.374 | 0.090 | 0.094 | 93.10% | 67.80% | 92.50% |
 | J2R (P-) | 0.142 | 0.185 | 0.054 | 0.060 | 0.122 | 0.125 | 87.70% | 96.10% | 89.50% |
 | CDR (P-) | -0.039 | 0.124 | 0.054 | 0.060 | 0.056 | 0.061 | 95.50% | 94.80% | 96.40% |
 | CR (P-) | -0.102 | 0.156 | 0.54 | 0.060 | 0.095 | 0.098 | 93.10% | 92.70% | 95.40% |